TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation

Abstract

Protein interaction is critical molecular regulatory activity underlining cellular functions and precise cell fate choices. Using TWIST1 BioID-proximity-labelling and network propagation analyses, we discovered and characterized a TWIST-chromatin regulatory module (TWIST1-CRM) in the neural crest cells (NCC). Combinatorial perturbation of core members of TWIST1-CRM: TWIST1, CHD7, CHD8, and WHSC1 in cell models and mouse embryos revealed that loss of the function of the regulatory module resulted in abnormal differentiation of NCCs and compromised craniofacial tissue patterning. Following NCC delamination, low level of TWIST1-CRM activity is instrumental to stabilize the early NCC signatures and migratory potential by repressing the neural stem cell programs. High level of TWIST1 module activity at later phases commits the cells to the ectomesenchyme. Our study further revealed the functional interdependency of TWIST1 and potential neurocristopathy factors in NCC development.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. Sequencing data have been deposited in GEO under accession codes GSE130251. External data analyzed has been listed in Supplementary File 6.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Xiaochen Fan

    Embryology, CMRI, The University of Sydney, Sydney, Australia
    For correspondence
    x6fan@eng.ucsd.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4316-0616
  2. V Pragathi Masamsetti

    Embryology Unit, CMRI, The University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Jane QJ Sun

    Embryology Unit, CMRI, The University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  4. Kasper Engholm-Keller

    Synapse Proteomics Group, CMRI, The University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Pierre Osteil

    Embryology Unit, CMRI, The University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Joshua Studdert

    Embryology Unit, CMRI, The University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  7. Mark E Graham

    Synapse Proteomics, CMRI, The University of Sydney, Westmead, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7290-1217
  8. Nicolas Fossat

    Embryology Unit, CMRI, The University of Sydney, Sydney, Australia
    For correspondence
    nfossat@sund.ku.dk
    Competing interests
    The authors declare that no competing interests exist.
  9. Patrick PL Tam

    Embryology Unit, CMRI, The University of Sydney, Westmead, Australia
    For correspondence
    PTam@cmri.org.au
    Competing interests
    The authors declare that no competing interests exist.

Funding

National Health and Medical Research Council (1066832,1079160,1003100,1110751)

  • Mark E Graham
  • Patrick PL Tam

Australian Research Council (1094008)

  • Xiaochen Fan
  • Patrick PL Tam

University of Sydney

  • Xiaochen Fan

Children's Medical Research Institute

  • Xiaochen Fan
  • Pierre Osteil
  • Nicolas Fossat

Carlsbergfondet (CF15-1056,CF16-0066)

  • Kasper Engholm-Keller

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Animal experimentations were performed in compliance with animal ethics and welfare guidelines stipulated by the Children's Medical Research Institute/Children's Hospital at Westmead Animal Ethics Committee, protocol number C230.

Reviewing Editor

  1. Marianne E Bronner, California Institute of Technology, United States

Publication history

  1. Received: September 7, 2020
  2. Accepted: February 5, 2021
  3. Accepted Manuscript published: February 8, 2021 (version 1)
  4. Version of Record published: March 17, 2021 (version 2)

Copyright

© 2021, Fan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,429
    Page views
  • 396
    Downloads
  • 10
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Xiaochen Fan
  2. V Pragathi Masamsetti
  3. Jane QJ Sun
  4. Kasper Engholm-Keller
  5. Pierre Osteil
  6. Joshua Studdert
  7. Mark E Graham
  8. Nicolas Fossat
  9. Patrick PL Tam
(2021)
TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation
eLife 10:e62873.
https://doi.org/10.7554/eLife.62873

Further reading

    1. Cell Biology
    John G Dingus, Jonathan CY Tang ... Constance L Cepko
    Research Article

    Conventional antibodies and their derived fragments are difficult to deploy against intracellular targets in live cells, due to their bulk and structural complexity. Nanobodies provide an alternative modality, with well-documented examples of intracellular expression. Despite their promise as intracellular reagents, there has not been a systematic study of nanobody intracellular expression. Here, we examined intracellular expression of 75 nanobodies from the Protein Data Bank. Surprisingly, a majority of these nanobodies were unstable in cells, illustrated by aggregation and clearance. Using comparative analysis and framework mutagenesis, we developed a general approach that stabilized a great majority of nanobodies that were originally unstable intracellularly, without significantly compromising target binding. This approach led to the identification of distinct sequence features that impacted the intracellular stability of tested nanobodies. Mutationally stabilized nanobody expression was found to extend to in vivo contexts, in the murine retina and in E. coli. These data provide for improvements in nanobody engineering for intracellular applications, potentiating a growing field of intracellular interrogation and intervention.

    1. Cell Biology
    Benjamin Barsi-Rhyne, Aashish Manglik, Mark von Zastrow
    Research Article Updated

    β-Arrestins are master regulators of cellular signaling that operate by desensitizing ligand-activated G-protein-coupled receptors (GPCRs) at the plasma membrane and promoting their subsequent endocytosis. The endocytic activity of β-arrestins is ligand dependent, triggered by GPCR binding, and increasingly recognized to have a multitude of downstream signaling and trafficking consequences that are specifically programmed by the bound GPCR. However, only one biochemical ‘mode’ for GPCR-mediated triggering of the endocytic activity is presently known – displacement of the β-arrestin C-terminus (CT) to expose clathrin-coated pit-binding determinants that are masked in the inactive state. Here, we revise this view by uncovering a second mode of GPCR-triggered endocytic activity that is independent of the β-arrestin CT and, instead, requires the cytosolic base of the β-arrestin C-lobe (CLB). We further show each of the discrete endocytic modes is triggered in a receptor-specific manner, with GPCRs that bind β-arrestin transiently (‘class A’) primarily triggering the CLB-dependent mode and GPCRs that bind more stably (‘class B’) triggering both the CT and CLB-dependent modes in combination. Moreover, we show that different modes have opposing effects on the net signaling output of receptors – with the CLB-dependent mode promoting rapid signal desensitization and the CT-dependent mode enabling prolonged signaling. Together, these results fundamentally revise understanding of how β-arrestins operate as efficient endocytic adaptors while facilitating diversity and flexibility in the control of cell signaling.